DONALD GARDNER
HOUSTON, TX NPI 1174616619
Browse related groups: TX Lilly USA, LLC All categories
General Payments — all program years on this page
$12,551.43
- Category: General Payments
- Program years: PY2018–2024
- Record count: 587
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,891.75 across 82 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,891.75 | 82 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $575.30 | 15 |
| Novo Nordisk AS | $226.77 | 11 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $143.98 | 6 |
| MannKind Corporation | $137.94 | 9 |
| Amgen Inc. | $134.36 | 9 |
| Radius Health, Inc. | $83.09 | 5 |
| Abbott Laboratories | $64.86 | 3 |
| Insulet Corporation | $63.67 | 3 |
| Ultragenyx Pharmaceutical Inc. | $62.30 | 1 |
| Embecta Corp. | $60.37 | 3 |
| Corcept Therapeutics | $59.22 | 3 |
| Kyowa Kirin, Inc. | $43.15 | 2 |
| Currax Pharmaceuticals LLC | $40.31 | 3 |
| Alexion Pharmaceuticals, Inc. | $31.04 | 1 |
| Ascensia Diabetes Care US Inc. | $28.90 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $28.04 | 1 |
| SANOFI-AVENTIS U.S. LLC | $23.86 | 1 |
| Xeris Pharmaceuticals, Inc. | $20.13 | 1 |
| Amneal Pharmaceuticals LLC | $18.80 | 1 |
| ABBVIE INC. | $18.52 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $13.71 | 1 |
| IBSA Pharma Inc. | $13.43 | 1 |
By program year
Records — PY2024 (82)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.